200 related articles for article (PubMed ID: 29628275)
1. Peripheral Serotonin Synthesis as a New Drug Target.
Matthes S; Bader M
Trends Pharmacol Sci; 2018 Jun; 39(6):560-572. PubMed ID: 29628275
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of serotonin synthesis: A novel therapeutic paradigm.
Bader M
Pharmacol Ther; 2020 Jan; 205():107423. PubMed ID: 31629717
[TBL] [Abstract][Full Text] [Related]
3. Blocking peripheral serotonin synthesis by telotristat etiprate (LX1032/LX1606) reduces severity of both chemical- and infection-induced intestinal inflammation.
Kim JJ; Wang H; Terc JD; Zambrowicz B; Yang QM; Khan WI
Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(6):G455-65. PubMed ID: 26206858
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.
Liu Q; Yang Q; Sun W; Vogel P; Heydorn W; Yu XQ; Hu Z; Yu W; Jonas B; Pineda R; Calderon-Gay V; Germann M; O'Neill E; Brommage R; Cullinan E; Platt K; Wilson A; Powell D; Sands A; Zambrowicz B; Shi ZC
J Pharmacol Exp Ther; 2008 Apr; 325(1):47-55. PubMed ID: 18192499
[TBL] [Abstract][Full Text] [Related]
5. Discovery and characterization of a novel tryptophan hydroxylase 1 inhibitor as a prodrug.
Shi H; Cui Y; Qin Y
Chem Biol Drug Des; 2018 Jan; 91(1):202-212. PubMed ID: 28719094
[TBL] [Abstract][Full Text] [Related]
6. Serotonin biosynthesis as a predictive marker of serotonin pharmacodynamics and disease-induced dysregulation.
Welford RW; Vercauteren M; Trébaul A; Cattaneo C; Eckert D; Garzotti M; Sieber P; Segrestaa J; Studer R; Groenen PM; Nayler O
Sci Rep; 2016 Jul; 6():30059. PubMed ID: 27444653
[TBL] [Abstract][Full Text] [Related]
7. The ever-changing roles of serotonin.
Jones LA; Sun EW; Martin AM; Keating DJ
Int J Biochem Cell Biol; 2020 Aug; 125():105776. PubMed ID: 32479926
[TBL] [Abstract][Full Text] [Related]
8. Enteric serotonin and oxytocin: endogenous regulation of severity in a murine model of necrotizing enterocolitis.
Gross Margolis K; Vittorio J; Talavera M; Gluck K; Li Z; Iuga A; Stevanovic K; Saurman V; Israelyan N; Welch MG; Gershon MD
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G386-G398. PubMed ID: 28774871
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.
Margolis KG; Stevanovic K; Li Z; Yang QM; Oravecz T; Zambrowicz B; Jhaver KG; Diacou A; Gershon MD
Gut; 2014 Jun; 63(6):928-37. PubMed ID: 23749550
[TBL] [Abstract][Full Text] [Related]
10. Production of serotonin by tryptophan hydroxylase 1 and release via platelets contribute to allergic airway inflammation.
Dürk T; Duerschmied D; Müller T; Grimm M; Reuter S; Vieira RP; Ayata K; Cicko S; Sorichter S; Walther DJ; Virchow JC; Taube C; Idzko M
Am J Respir Crit Care Med; 2013 Mar; 187(5):476-85. PubMed ID: 23328530
[TBL] [Abstract][Full Text] [Related]
11. [Abnormal cardiac activity in mice in the absence of peripheral serotonin synthesis].
Côté F; Fligny C; Mallet J; Vodjdani G
J Soc Biol; 2004; 198(1):7-17. PubMed ID: 15146950
[TBL] [Abstract][Full Text] [Related]
12. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice.
Izikki M; Hanoun N; Marcos E; Savale L; Barlier-Mur AM; Saurini F; Eddahibi S; Hamon M; Adnot S
Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L1045-52. PubMed ID: 17675372
[TBL] [Abstract][Full Text] [Related]
13. Telotristat Ethyl: First Global Approval.
Markham A
Drugs; 2017 May; 77(7):793-798. PubMed ID: 28382568
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease.
Waløen K; Kleppe R; Martinez A; Haavik J
Expert Opin Ther Targets; 2017 Feb; 21(2):167-180. PubMed ID: 27973928
[TBL] [Abstract][Full Text] [Related]
15. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels.
Nakamura K; Sugawara Y; Sawabe K; Ohashi A; Tsurui H; Xiu Y; Ohtsuji M; Lin QS; Nishimura H; Hasegawa H; Hirose S
J Neurosci; 2006 Jan; 26(2):530-4. PubMed ID: 16407550
[TBL] [Abstract][Full Text] [Related]
16. Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells.
Herrera-Martínez AD; Feelders RA; Van den Dungen R; Dogan-Oruc F; van Koetsveld PM; Castaño JP; de Herder WW; Hofland LJ
Neuroendocrinology; 2020; 110(5):351-363. PubMed ID: 31319410
[TBL] [Abstract][Full Text] [Related]
17. Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea.
Lyseng-Williamson KA
Drugs; 2018 Jun; 78(9):941-950. PubMed ID: 29931594
[TBL] [Abstract][Full Text] [Related]
18. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants.
Savelieva KV; Zhao S; Pogorelov VM; Rajan I; Yang Q; Cullinan E; Lanthorn TH
PLoS One; 2008; 3(10):e3301. PubMed ID: 18923670
[TBL] [Abstract][Full Text] [Related]
19. Telotristat ethyl: a new option for the management of carcinoid syndrome.
Lamarca A; Barriuso J; McNamara MG; Hubner RA; Valle JW
Expert Opin Pharmacother; 2016 Dec; 17(18):2487-2498. PubMed ID: 27817224
[TBL] [Abstract][Full Text] [Related]
20. Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.
Shi ZC; Devasagayaraj A; Gu K; Jin H; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; Kimball SD; Main AJ; Sun W; Yang Q; Nouraldeen A; Yu XQ; Buxton E; Patel S; Nguyen N; Swaffield J; Powell DR; Wilson A; Liu Q
J Med Chem; 2008 Jul; 51(13):3684-7. PubMed ID: 18557609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
